                         SEQUENCE LISTING

<110>  The Johns Hopkins University
       Regents of the University of Minnesota
 
<120>  TREATING CANCER

<130>  44807-0397WO1

<140>  PCT/US2022/026464
<141>  2022-04-27

<150>  63/180,995
<151>  2021-04-28

<160>  22    

<170>  PatentIn version 3.5

<210>  1
<211>  22
<212>  RNA
<213>  Artificial

<220>
<223>  miR-603 microRNA sequence

<400>  1
cacacacugc aauuacuuuu gc                                                22


<210>  2
<211>  22
<212>  RNA
<213>  Artificial

<220>
<223>  miR-603 microRNA sequence

<400>  2
aaaaguaauu gcagugugug uu                                                22


<210>  3
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  polypeptide that can be included in a targeting moiety that can 
       bind integrin alpha 5 beta 1 polypeptides

<400>  3

Arg Gly Asp Ser Pro 
1               5   


<210>  4
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  polypeptide that can be included in a targeting moiety that can 
       bind integrin alpha5beta1 polypeptides

<400>  4

Pro His Ser Arg Asn 
1               5   


<210>  5
<211>  23
<212>  PRT
<213>  Artificial

<220>
<223>  polypeptide that can be included in a targeting moiety that can 
       bind integrin alpha5beta1 polypeptides

<400>  5

Lys Ser Ser Pro His Ser Arg Asn Ser Gly Ser Gly Ser Gly Ser Gly 
1               5                   10                  15      


Ser Gly Arg Gly Asp Ser Pro 
            20              


<210>  6
<211>  18
<212>  PRT
<213>  Artificial

<220>
<223>  polypeptide that can be included in a targeting moiety that can 
       bind integrin alpha5beta1 polypeptides

<400>  6

Pro His Ser Arg Asn Ser Gly Ser Gly Ser Gly Ser Gly Arg Gly Asp 
1               5                   10                  15      


Ser Pro 
        


<210>  7
<211>  23
<212>  PRT
<213>  Artificial

<220>
<223>  polypeptide that can be included in a targeting moiety that can 
       bind integrin alpha5beta1 polypeptides

<400>  7

Lys Ser Ser Pro His Ser Arg Asn Gly Gly Gly Gly Gly Gly Gly Gly 
1               5                   10                  15      


Gly Gly Arg Gly Asp Ser Pro 
            20              


<210>  8
<211>  24
<212>  PRT
<213>  Artificial

<220>
<223>  polypeptide that can be included in a targeting moiety that can 
       bind integrin alpha5beta1 polypeptides

<400>  8

Lys Ser Ser Pro His Ser Arg Asn Ser Ser Ser Ser Ser Ser Ser Ser 
1               5                   10                  15      


Ser Ser Gly Arg Gly Asp Ser Pro 
            20                  


<210>  9
<211>  20
<212>  PRT
<213>  Artificial

<220>
<223>  polypeptide that can be included in a targeting moiety that can 
       bind integrin alpha5beta1 polypeptides

<400>  9

Pro His Ser Arg Asn Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Arg 
1               5                   10                  15      


Gly Asp Ser Pro 
            20  


<210>  10
<211>  26
<212>  PRT
<213>  Artificial

<220>
<223>  polypeptide that can be included in a targeting moiety that can 
       bind integrin alpha5beta1 polypeptides

<400>  10

Lys Ser Ser Ser Ser Ser Pro His Ser Arg Asn Ser Gly Ser Gly Ser 
1               5                   10                  15      


Gly Ser Gly Ser Gly Arg Gly Asp Ser Pro 
            20                  25      


<210>  11
<211>  20
<212>  DNA
<213>  Artificial

<220>
<223>  synthetic oligonucleotide primer

<400>  11
gcagcactca tccacgatgc                                                   20


<210>  12
<211>  24
<212>  DNA
<213>  Artificial

<220>
<223>  synthetic oligonucleotide primer

<400>  12
tgtggagaca ggggctttta tttc                                              24


<210>  13
<211>  19
<212>  DNA
<213>  Artificial

<220>
<223>  synthetic oligonucleotide primer

<400>  13
aagttctggt tgtcgagga                                                    19


<210>  14
<211>  21
<212>  DNA
<213>  Artificial

<220>
<223>  synthetic oligonucleotide primer

<400>  14
gagcagctag aagggaatta c                                                 21


<210>  15
<211>  19
<212>  DNA
<213>  Artificial

<220>
<223>  synthetic oligonucleotide primer

<400>  15
ttgccctcca atggatcct                                                    19


<210>  16
<211>  26
<212>  DNA
<213>  Artificial

<220>
<223>  synthetic oligonucleotide primer

<400>  16
gggaggtagt gacgaaaaat aacaat                                            26


<210>  17
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  linker that can be included in a targeting moiety that can bind 
       integrin alpha5beta1 polypeptides

<400>  17

Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly 
1               5                   10  


<210>  18
<211>  8
<212>  PRT
<213>  Artificial

<220>
<223>  linker that can be included in a targeting moiety that can bind 
       integrin alpha5beta1 polypeptides

<400>  18

Ser Gly Ser Gly Ser Gly Ser Gly 
1               5               


<210>  19
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  linker that can included in a targeting moiety that can bind 
       integrin alpha5beta1 polypeptides

<400>  19

Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
1               5                   10  


<210>  20
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  linker that can be included in a targeting moiety that can bind 
       integrin alpha5beta1 polypeptides

<400>  20

Ser Ser Ser Ser Ser Ser Ser Ser Ser Ser 
1               5                   10  


<210>  21
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  polypeptide that can be included in a targeting moiety that can 
       bind integrin alpha5beta1 polypeptides

<400>  21

Gly Arg Gly Asp Ser Pro 
1               5       


<210>  22
<211>  22
<212>  DNA
<213>  Artificial

<220>
<223>  anti-miR-21 anti-microRNA sequence

<400>  22
tcaacatcag tctgataagc ta                                                22


